Skip to main content
. 2017 Nov 18;8(62):105957–105970. doi: 10.18632/oncotarget.22515

Figure 1. Kaplan-Meier survival analysis of +3027C/A HLA-G polymorphisms.

Figure 1

Kaplan Meier survival curves show 72.3% and 34% EFS for patients with the +3027 C/C and C/A variant, respectively (C/A vs. C/C, HR=3.23, 95% CI 0.99-10.54; P=0.012). The solitary patient with A/A genotype was excluded from the analysis.